Skip to main content
. 2023 Feb 16;28(4):1871. doi: 10.3390/molecules28041871

Figure 5.

Figure 5

Determination of the in vitro activity of Breastin in various human solid cancer cell lines of the RGCC panel as measured by the MTT assay. We tested HCT-116 colorectal carcinoma, MCF-7 and MDA-MB-231 breast adenocarcinoma, MOR lung adenocarcinoma, PANC-1 pancreatic carcinoma, and LnCaP prostate adenocarcinoma cells. 4-Hydroxycyclophosphamide (HO-CTX) was used as control drug.